|
Volumn 21, Issue 6, 2005, Pages 789-790
|
Infliximab and the bone in Crohn's disease [1]
|
Author keywords
[No Author keywords available]
|
Indexed keywords
ALKALINE PHOSPHATASE;
DEOXYPYRIDINOLINE;
INFLIXIMAB;
ADULT;
BONE;
BONE DENSITY;
CLINICAL ARTICLE;
CROHN DISEASE;
DRUG EFFICACY;
FRACTURE;
HUMAN;
LETTER;
MALE;
OSSIFICATION;
OSTEOLYSIS;
PRIORITY JOURNAL;
RISK FACTOR;
ADULT;
ANTIBODIES, MONOCLONAL;
BONE DENSITY;
CROHN DISEASE;
GASTROINTESTINAL AGENTS;
HUMANS;
MALE;
OSTEOGENESIS;
|
EID: 16344387364
PISSN: 02692813
EISSN: None
Source Type: Journal
DOI: 10.1111/j.1365-2036.2005.02400.x Document Type: Letter |
Times cited : (1)
|
References (8)
|